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INTRODUCTION. Invasive aspergillosis (IA) is a fungal infection particularly affecting 
immunocompromized hosts. In the past decade, however, several reports indicate an 
important occurrence rate of IA in apparently immunocompetent ICU patients. Little is 
known about the specific risk profile of ICU patients to develop IA. 
OBJECTIVES. To describe characteristics and outcome in ICU patients with IA. 
METHODS. We report an interim analysis of the AspICU project (www.aspicu.org), a 
multicenter (n=24) observational survey (Nov. 2006-Nov. 2009) of all ICU patients 
with a positive Aspergillus culture. IA was defined according to an algorithm that 
discriminates Aspergillus colonization from probable or proven IA [1]. 
RESULTS. At time of interim analysis 390 patients were included in the AspICU 
project. Of these, 183 cases (46.9%) were classified as IA (of which 44 proven and 
139 probable IA). The lung was the most frequent site of infection (97.8%) and A. 
fumigatus the most common isolated species (93.0%). The median APACHE II score 
at admission was 26 (IQR 18-30) and the median SOFA score at time of diagnosis of 
IA was 9 (IQR 6-13). IA was generally diagnosed in medical ICUs (82.0%). The most 
frequently observed co-morbid conditions or underlying diseases were COPD 
(37.2%), ARDS (19.0%), diabetes mellitus (13.7%), and chronic heart failure (8.7%). 
There were 26 patients (14.2%) with solid organ transplantation (12 liver, 7 kidney, 5 
lung, and 2 heart transplants). Only 35.0% of patients had classical host factors as 
defined by the EORTC/MSG, such as neutropenia (6.6%), hemato-oncological 
malignancy treated with cytotoxic agents (8.7%), bone marrow transplantation 
(2.7%), or chronic use of corticosteroids (15.3%). Clinical signs suggestive for IA 
were dyspnea (63%), worsening respiratory insufficiency in spite of antibiotic therapy 
and ventilator support (56%), and fever refractory to at least 3 days of antibiotic 
therapy (34%). Medical imaging (either by CT or on Chest X-ray) showed non-
specific infiltrates (72%), pleural fluid (26%), diffuse “ARDS-like” infiltrates (20%), 
nodules (21%), wedge-shaped infiltrates (5%), cavitation (4%), Halo sign (3%), and 
air crescent sign (2%). Mortality at 12 weeks after diagnosis was 69.8% in proven IA 
and 67.2% in probable IA. 
CONCLUSIONS. IA in ICUs is associated with high mortality. Classical host factors 
and medical imaging suggestive for IA were rather rare. COPD is the most frequent 
frequent underlying condition.  
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